Sling Therapeutics Starts Phase 3 Trial of Linsitinib
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
pharmaceutical research
Advertisement
The Braff Group Advises CCR on PhaseWell Partnership
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
QurCan Therapeutics and Lilly Advance Nucleic Acid Therapies
Cambridge, Massachusetts, September 15, 2026 QurCan Therapeutics has entered into a strategic research and collaboration agreement with Eli Lilly...
Lundbeck Completes Enrollment in Phase III Dravet Trial
Copenhagen, Denmark, September 15, 2026 H. Lundbeck A/S has announced that the last patient has been randomized in DEEp...
PharmAla Advances MDXX Manufacturing and Drug Pipeline
Toronto, Ontario, Canada, August 21, 2026 PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and...
Advertisements
Sitero Expands Clinical AI Across the Data Lifecycle
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
Helus Pharma Completes Phase 3 HLP003 Enrollment in MDD
NEW YORK and TORONTO, Aug. 14, 2026 Helus Pharma is advancing its late-stage clinical development strategy for novel serotonergic...
Sagimet Biosciences Secures FDA Clearance for Acne Phase 3 Trial
FOSTER CITY, Calif., August 13, 2026 Sagimet Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103
Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...
Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Advertisement
